IL22 and colitis: Recently, it has been shown that KD can reduce RORγt+CD3− Group 3 ILCs and the production of related inflammatory cytokines including IL-17α, IL-18, IL-22, and Ccl4 in DSS induced colitis, protecting intestinal barrier function (Fig. 2).